American Renal Associates (ARA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 100,905 | 105,149 | 93,268 | 95,965 | 90,988 |
| Receivables | 130,211 | 81,909 | 77,048 | 78,492 | 79,605 |
| Inventories | 4,676 | 4,468 | 4,790 | 5,515 | 4,291 |
| TOTAL | $254,290 | $204,477 | $190,083 | $199,479 | $193,747 |
| Non-Current Assets | |||||
| PPE Net | 170,118 | 165,132 | 160,887 | 151,204 | 142,701 |
| Intangibles | 598,718 | 599,050 | 595,868 | 595,192 | 594,980 |
| Other Non-Current Assets | 17,102 | 6,593 | 6,174 | 6,574 | 6,850 |
| TOTAL | $785,938 | $770,775 | $762,929 | $752,970 | $744,531 |
| Total Assets | $1,040,228 | $975,252 | $953,012 | $952,449 | $938,278 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 48,274 | 43,582 | 40,579 | 27,171 | 25,610 |
| Accounts payable and accrued liabilities | 31,127 | 23,277 | 23,515 | 23,857 | 22,571 |
| Accrued Expenses | 92,125 | 83,123 | 71,111 | 52,606 | 49,292 |
| TOTAL | $171,526 | $149,982 | $135,205 | $103,634 | $97,473 |
| Non-Current Liabilities | |||||
| Long Term Debt | 522,058 | 520,017 | 517,798 | 661,369 | 657,372 |
| Other Non-Current Liabilities | 149,310 | 143,646 | 150,435 | 98,540 | 96,816 |
| TOTAL | $704,977 | $694,007 | $697,890 | $793,806 | $790,095 |
| Total Liabilities | $876,503 | $843,989 | $833,095 | $897,440 | $887,568 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 30,895 | 30,868 | 30,868 | 22,220 | N/A |
| Common Shares | 184 | 184 | 184 | 98 | 98 |
| Retained earnings | -131,301 | -121,527 | -133,597 | -124,505 | -128,261 |
| Other shareholders' equity | 194,155 | 182,841 | 180,925 | 178,959 | 178,873 |
| TOTAL | $163,725 | $131,263 | $119,917 | $55,009 | $50,710 |
| Total Liabilities And Equity | $1,040,228 | $975,252 | $953,012 | $952,449 | $938,278 |